How is PEG-MGF administered?
This describes how PEG-MGF is typically administered in clinical and research references, not a self-administration guide. The usual route is Subcutaneous, on a post-workout, 1-2x weekly schedule, generally over 4-6 weeks max. Specific dosing is individual and beyond general information, and human evidence for PEG-MGF is limited.
Administration at a glance (reference data)
- Route: Subcutaneous
- Schedule: Post-workout, 1-2x weekly
- Cycle length: 4-6 weeks max
- Half-life: ~3-6 hours
References
- Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation — Yang SY & Goldspink G, FEBS Letters, 2002
- Mechano-Growth Factor: an important cog or a loose screw in the repair machinery? — Zabłocka B, Goldspink PH, Goldspink G, Górecki DC, Frontiers in Endocrinology, 2012
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on PEG-MGF
Last updated 2026-06-15.